Beauty

CTPA panel: context, consistency and listening are key to countering beauty misinformation

At the CTPA’s inaugural scientific conference, scientists, government officials and communicators discussed how to explain evidence and reach consumers who remain uncertain.

Dalia MansourOctober 27, 20265 min read2 views

A glass beaker with a suspended droplet, a magnifying glass and a faint pool reflection on a neutral surface, illustrating scientific context and careful communication.

At the UK Cosmetic, Toiletry and Perfumery Association’s (CTPA) inaugural scientific conference, a panel of government and industry specialists examined how the beauty sector can counter misinformation and build public trust in scientific evidence. The members-only event, held at Central Hall Westminster in London, focused on strategies for public, media and consumer engagement and on how scientific evidence, regulatory decision-making and public understanding can converge at a time of information overload.

In opening remarks, Caroline Rainsford, director of science at the CTPA, said strong science communication is essential because people in different roles spend their days translating complex scientific information for audiences. During a later panel on building trust through science communication, she stressed the value of putting science into context for consumers. She recalled a discussion with salon professionals about an ingredient banned in nail polish, explaining that a person would have to wear two kilograms of nail polish to approach the level that causes harm.

Marc Pissavini, sun research lab director at Coty, agreed that context matters. He pointed to an Olympic swimming pool as an analogy for liquid relevance: at two litres a day, one pool would take an individual around 4,500 years to drink, so a single drop in that pool is negligible. To fight misinformation, he said, the first step is to explain and give consumers the means to measure or understand the issue.

Pissavini also linked credibility to consistency. He argued that science needs a unified voice, and that dermatologists, doctors, major companies and others would be stronger if they spoke collectively rather than individually, as pharmacy and large groups do. Wendy Middleton, chief scientific officer and director for science at the UK government’s Office for Product Safety and Standards, said the idea of a single voice was interesting but also exposed a weakness: scientists are not very good at speaking with one voice. She noted that credible science depends on critique and peer review, and said the profession should become more aware of how it communicates internally.

Peer review itself came under discussion. Pissavini, who is also editor of the peer-reviewed International Journal of Cosmetic Science, said the scientific community must keep the peer review process, while acknowledging the challenge of finding reviewers and communicating better with readers both inside and outside the industry. Rainsford added that the industry needs to work collectively to demystify peer review. Most people do not understand how the process works, she said, including industry members, making transparency about what it involves important going forward.

Claire Coleman, a journalist, editor and specialist consultant on the science behind beauty, said efforts to correct misinformation should begin where it is found. Communicators need to meet people where they are and stand on the same platform, she said. Middleton agreed, arguing that consumers described as hard to reach are often not hard to reach but hard for the organisations trying to reach them to hear, and that listening more carefully is essential.

Coleman also cautioned that the industry cannot reach or convert everyone. Rather than targeting hard-liners, she said, communicators should focus on consumers who are undecided and want to understand better. Roger Pullin, head of chemicals policy and health at the UK Chemical Industries Association, said technical terms and acronyms should be avoided where possible. Messages should be precise and clear from a consumer perspective without losing the science, he said, though that is difficult with complex subjects such as risk-based exposure. He added that companies can offer a more balanced scientific perspective, be transparent about uncertainty and state directly what is unknown instead of avoiding awkward questions.

In closing remarks, Emma Meredith, director-general of the CTPA, said that how the industry communicates science, and whether it does so well, is critical.